Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2020

View Archived Issues

Biotest submits phase II study of trimodulin for severe COVID-19 in Spain

Centivax antibody shows potential as therapeutic and prophylactic in models of COVID-19

SMYD3 could be a potential therapeutic target in HNSCC

FDA reviews pre-IND application for Tetra's ARDS-003 to prevent COVID-19-related ARDS

PRX-034 and its prodrug PRX-007 as promising candidates for the treatment of cancer and COVID-19

Novel mouse model of prostate cancer to evaluate chemopreventive potential of pterostilbene

Shanghai Zheye Biotechnology patents ACVR1 inhibitors

Sichuan Kelun-Biotech Biopharmaceutical discloses adenosine A2A receptor antagonists

Chinese researchers divulge hSTING agonists

Carragelose shows efficacy against SARS-CoV-2 in cell culture assays

Medshine Discovery identifies FGFR and VEGFR dual inhibitors

68Ga-radiolabeled peptide targeting integrin alpha3beta1 developed to image pancreatic cancer

Hangzhou Bio-Creativity Pharma-Tech divulges CDK inhibitors

Positive preclinical results reported for LineaDNA COVID-19 vaccine candidates

Using red blood cells, EDITing strengthens immune response

Protein degradation system targeted to KRAS

First patient dosed in phase I/II study of bemcentinib in GBM

Antibody fragment-drug conjugates investigated as alternative to antibody-drug conjugates

Kringle begins phase III trial of KP-100IT for acute spinal cord injury in Japan

Synairgen reports promising data from SNG-001 trial in hospitalized COVID-19 patients

PLAC8 unveiled as a marker of chemoresistance in PSTT and choriocarcinoma

GSK initiates phase I study of S. aureus vaccine candidate GSK-3878858-A

Silverback begins first-in-human study of SBT-6050 in advanced HER2 solid tumors

Sage Therapeutics studies SAGE-324 in phase II for essential tremor

NFlection opens phase IIa study of NFX-179 for cutaneous neurofibromas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...